CSPC Hunan Jingfeng Pharmaceutical Co., Ltd. (SHE:000908)
China flag China · Delayed Price · Currency is CNY
4.740
-0.070 (-1.46%)
Nov 18, 2026, 3:04 PM CST

SHE:000908 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
403.88375.6411.27645.32822.56771.86
Other Revenue
2.512.514.7611.5818.139.33
406.39378.11416.03656.89840.66811.18
Revenue Growth
1.42%-9.12%-36.67%-21.86%3.63%-7.60%
Cost of Revenue
161.87151.12155.08197.92205.82323.64
Gross Profit
244.52226.99260.95458.97634.83487.55
Selling, General & Admin
249.48251.35249.61502.89591.81711.34
Research & Development
30.491113.0252.5135.6438.63
Other Operating Expenses
12.576.959.7210.7711.9827.36
Operating Expenses
294.79273.54266.27563.35654.27797.37
Operating Income
-50.28-46.55-5.31-104.38-19.44-309.83
Interest Expense
-19.74-30.37-40.34-41.89-52.23-85.85
Interest & Investment Income
48.4636.65264.45.31.12249.89
Currency Exchange Gain (Loss)
-0-00.030.040.15-0.05
Other Non Operating Income (Expenses)
19.2-1.130.810.511.85-19.08
EBT Excluding Unusual Items
-2.36-41.39219.6-140.42-68.54-164.92
Gain (Loss) on Sale of Investments
-16.53-16.53-1.2524.8113.82-3.79
Gain (Loss) on Sale of Assets
4.88-2.77-3.367.569.855.89
Asset Writedown
-3.81-4.34-19.03-83.76-39.56-42.79
Legal Settlements
-15.77-15.77-20.8-6.12-15.33-13.72
Other Unusual Items
12.033.2-10.623.3114.1713.89
Pretax Income
-21.56-77.6164.53-194.62-85.63-155.44
Income Tax Expense
0.781.445.0832.849.6246.2
Earnings From Continuing Operations
-22.35-79.05159.45-227.46-95.25-201.64
Minority Interest in Earnings
-3.2-1.84-7.14-8.64-27.3137.98
Net Income
-25.54-80.89152.3-236.1-122.56-163.66
Net Income to Common
-25.54-80.89152.3-236.1-122.56-163.66
Net Income Growth
------
Shares Outstanding (Basic)
1,370880880880880880
Shares Outstanding (Diluted)
1,370880880880880880
Shares Change
55.69%0.04%0.02%-0.02%-0.01%-0.36%
EPS (Basic)
-0.02-0.090.17-0.27-0.14-0.19
EPS (Diluted)
-0.02-0.090.17-0.27-0.14-0.19
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
-43.7754.76-6.9324.64109.7585.72
Free Cash Flow Per Share
-0.030.06-0.010.030.130.10
Gross Margin
60.17%60.03%62.72%69.87%75.52%60.10%
Operating Margin
-12.37%-12.31%-1.28%-15.89%-2.31%-38.19%
Profit Margin
-6.29%-21.39%36.61%-35.94%-14.58%-20.18%
Free Cash Flow Margin
-10.77%14.48%-1.67%3.75%13.05%10.57%
EBITDA
-19.71-17.821.03-65.3932.24-212.35
EBITDA Margin
-4.85%-4.71%5.05%-9.95%3.83%-26.18%
D&A For EBITDA
30.5628.7526.3438.9951.6897.47
EBIT
-50.28-46.55-5.31-104.38-19.44-309.83
EBIT Margin
-12.37%-12.31%-1.28%-15.89%-2.31%-38.19%
Effective Tax Rate
--3.09%---
Revenue as Reported
406.39378.11416.03656.89840.66811.18
Advertising Expenses
-2.053.9220.649.3673.33